Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Greg Spendjian who wrote (8667)	2/7/2002 9:24:40 PM
From: axial	Read Replies (1) \| Respond to of 14101

My understanding of the term non-compliance is that DMX was not compliant in supplying information to HC. That is, HC's complaint does not lie in the data,or the drug, but in the alleged failure of DMX to supply some component of information deemed necessary by HC. To my eyes, the following comment, "The directorate has raised issues, which the company believes should have been resolved by clarifying the information already submitted." This response would be stated something like this, in "other circles": "It's right there in front of your eyes, you buncha dummies! In 15 days, we'll draft an answer that will read the data for* you, seeing as you can't read it for yourselves!"* It was a pretty testy response. I liked it, a lot. Regards, Jim